Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
  1. Home
  2. Stock
  3. KVUE
KVUE logo

KVUE News & Events

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

KVUE News

FDA Approves Expanded Use of Wellcovorin for Cerebral Folate Deficiency

1d agoBenzinga

Dividend Kings: High-Quality Long-Term Investment Choices

1d agoFool

Genuine Parts Co. Split Plans May Unlock Value

1d agoNASDAQ.COM

Emerging Consolidation Wave in U.S. Markets

1d agoBenzinga

Analysis of Chewy's Undervalued Stock Reasons

2d agoCNBC

The Investment Advantage of High-Quality Dividend Stocks

3d agoFool

Dividend Stocks Outperform Non-Payers Significantly

3d agoNASDAQ.COM

Trump's Comments Lead to Drop in Tylenol Prescriptions for Pregnant Women

5d agoseekingalpha

KVUE Events

02/26 16:30
Nasdaq Lags Despite Nvidia's Earnings Beat and Strong Guidance
The major averages had a mixedclose with the Nasdaq the laggard despite an earnings beat and blowout guidance from Nvidia. The market's tepid reaction to the quarterly report suggests that confidence in the broader AI narrative remains far from unanimous.Mixed results from other major technology and software companies added complexity as weak guidance from some key SaaS names pulled back parts of the sector and weighed on overall sentiment as well.Looking to commodities, gold was fractionally lower as the asset continues to experience a volatile 2026, while oil was marginally lower.Get caught up quickly on the top news and calls moving stocks with these five Top Five lists.1. STOCK NEWS:Nvidiareportedand provided upbeat Q1 revenue guidanceSalesforcereportedand provided its outlook for Q1 and FY27Warner Bros. Discoveryreported, adding that HBO Max is "well on its way" to over 150M subscribersParamount Skydancereported a year-over-yearand reiterated its FY26 revenue guidanceSnowflakereportedand provided Q1 product revenue guidance2. WALL STREET CALLS:Joby Aviationto Buy at H.C. WainwrightSpotifyto Buy at AreteFirst Solarto Hold at Deutsche Bank after "disappointing" Q4Oddityto Underperform at BofA and downgraded to Underweight at BarclaysMosaicto Underweight at JPMorgan3. AROUND THE WEB:A Texas judge has rejected Kenvue'sbid to dismiss a state lawsuit over Tylenol, Reuters reportsTesla'sCybercab program manager has left the company before launch, Electrek sayseBayis cutting 6% of its full-time employees, or roughly 800 jobs, as the company feels the layoffs are needed to align its workforce with strategic priorities, Bloomberg reportsPayPalisn't currently in talks to sell itself to Stripe or anyone else and has been working for months with bankers to prepare for a potential activist campaign or unwanted takeover bid, Semafor saysJehoshaphat Research announced that it is short GPGI4. MOVERS:Krispy Kremeincreases afterand providing guidance for FY26Butterfly Networkgains afterand providing guidance for FY26Novavaxand Sezzlehigher in New York afterArray Technologiesfalls after, with EPS missing consensusEose Energylower afterand providing guidance for FY265. EARNINGS/GUIDANCE:Perrigo, with EPS and revenue lower year-over-yearLiberty Formula One, with CEO Derek Chang commenting on "an exceptional and productive year for Liberty"Hertzand provided guidance for Q1Standard Motor, with EPS beating consensusEmcorand provided guidance for FY26INDEXES:The Dow rose 17.05, or 0.034%, to 49,499.20, the Nasdaq lost 273.69, or 1.18%, to 22,878.38, and the S&P 500 declined 37.27, or 0.54%, to 6,908.86.
02/26 12:20
Texas Judge Dismisses Kenvue's Lawsuit Bid
Judge LeAnn Rafferty in Panola County, Texas dismissed Kenvue's bid to throw out a lawsuit by state Attorney General Ken Paxton claiming the company falsely marketed Tylenol by concealing autism and other risks to children when pregnant women use the drug, Reuters' Jonathan Stempel reports. The judge denied Kenvue's request in a one-sentence order, the authors say, noting her reasoning for the determination was not immediately available.

KVUE Monitor News

Kenvue Shares Hit 20-Day High Amid Dividend Ruling

Nov 17 2025

KVUE Earnings Analysis

Kenvue Q2 Earnings: Strategic Shift and Future Prospects- Intellectia AI™
7 months ago
Steady Performance Amid Challenges - Intellectia AI™
1 years ago
Kenvue Inc Reports Third Quarter 2024 Financial Results
1 years ago

People Also Watch